European Medicines Agency (EMA)
The EMEA was established by Council Regulation (EEC) No 2309/93 of 22 July 1993 and London was chosen as its seat. The agency is in charge of coordinating scientific resources existing in Member States with a view to evaluating and supervising medicinal products for both human and veterinary use. On the basis of the Agency’s opinion, the European Commission authorizes the marketing of new medicinal products and arbitrates between Member States for other medicinal products in case of disagreement. Information about regulation of gene and cell therapy can be searched on the EMEA Web Site. Currently, you can find on the EMEA webpage under "Human Medicines" the section "Advanced Therapies" with information relevant for gene and cell therapy.
The common Website for the medicines authorities in the European Union (Heads of Medicines Agencies) is http://www.hma.eu/.
NATIONAL MEDICAL AGENCIES
Under http://www.hma.eu/ you will find a list with links to the EU Member State Medicines Agencies. You can find those specific to your country by following the link "Choose your country".
||Therapeutic Goods Administration (TGA)
||Health Protection Branch, Health Canada
||National Agency for Medicines
||Agence du Médicament
||National Drug Organization
||Irish Medicines Board
||Ministry oh Health
||National Institute of Health Sciences
||Medicines Evaluation Board
||National Institute of Pharmacy and Medicines
||Spanish Agency for Medical Products